300
Participants
Start Date
Not specified
Primary Completion Date
May 31, 1999
Indinavir sulfate
Delavirdine mesylate
Lamivudine
Stavudine
Zidovudine
Beth Israel Med Ctr, New York
SUNY / Erie County Med Ctr at Buffalo, Buffalo
Univ of Rochester Medical Center, Rochester
Univ of Pennsylvania at Philadelphia, Philadelphia
Johns Hopkins Hosp, Baltimore
Moses H Cone Memorial Hosp, Greensboro
Carolinas Med Ctr, Charlotte
Julio Arroyo, West Columbia
Univ of Alabama at Birmingham, Birmingham
Northwestern Univ Med School, Chicago
Cook County Hosp, Chicago
Rush Presbyterian - Saint Luke's Med Ctr, Chicago
Louis A Weiss Memorial Hosp, Chicago
St Louis Regional Hosp / St Louis Regional Med Ctr, St Louis
Univ of Colorado Health Sciences Ctr, Denver
Stanford at Kaiser / Kaiser Permanente Med Ctr, San Francisco
Queens Med Ctr, Honolulu
Univ of Hawaii, Honolulu
State of MD Div of Corrections / Johns Hopkins Univ Hosp, Baltimore
Univ of North Carolina, Chapel Hill
Univ of Miami School of Medicine, Miami
Ohio State Univ Hosp Clinic, Columbus
MetroHealth Med Ctr, Cleveland
Indiana Univ Hosp, Indianapolis
Univ of California / San Diego Treatment Ctr, San Diego
San Mateo AIDS Program / Stanford Univ, Stanford
Stanford Univ Med Ctr, Stanford
Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium, San Jose
Univ of Washington, Seattle
Beth Israel Deaconess - West Campus, Boston
Univ of Puerto Rico, San Juan
National Institute of Allergy and Infectious Diseases (NIAID)
NIH